New data point to strong protection against respiratory syncytial virus from RSV vaccines and monoclonal antibody treatments, while separate mouse research suggests viral infections may leave lasting immune damage.
RSV vaccines and antibody shots sharply cut infections, data show
New data point to strong protection against respiratory syncytial virus from RSV vaccines and monoclonal antibody treatments, while separate mouse research suggests viral infections may leave lasting immune damage.
Airman Joseph R Schmitt, U.S. Navy · Public domain · rights
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.